These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8841021)

  • 1. Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China.
    Han C; Qiao G; Hubbert NL; Li L; Sun C; Wang Y; Yan M; Xu D; Li Y; Lowy DR; Schiller JT
    J Natl Cancer Inst; 1996 Oct; 88(20):1467-71. PubMed ID: 8841021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden.
    Lagergren J; Wang Z; Bergström R; Dillner J; Nyrén O
    J Natl Cancer Inst; 1999 Jan; 91(2):156-62. PubMed ID: 9923857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers.
    Sitas F; Egger S; Urban MI; Taylor PR; Abnet CC; Boffetta P; O'Connell DL; Whiteman DC; Brennan P; Malekzadeh R; Pawlita M; Dawsey SM; Waterboer T;
    J Natl Cancer Inst; 2012 Jan; 104(2):147-58. PubMed ID: 22228147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
    Nonnenmacher B; Kruger Kjaer S; Svare EI; Scott JD; Hubbert NL; van den Brule AJ; Kirnbauer R; Walboomers JM; Lowy DR; Schiller JT
    Int J Cancer; 1996 Dec; 68(6):704-9. PubMed ID: 8980170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China.
    Kamangar F; Qiao YL; Schiller JT; Dawsey SM; Fears T; Sun XD; Abnet CC; Zhao P; Taylor PR; Mark SD
    Int J Cancer; 2006 Aug; 119(3):579-84. PubMed ID: 16496409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
    J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
    Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
    Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
    Herrero R; Castellsagué X; Pawlita M; Lissowska J; Kee F; Balaram P; Rajkumar T; Sridhar H; Rose B; Pintos J; Fernández L; Idris A; Sánchez MJ; Nieto A; Talamini R; Tavani A; Bosch FX; Reidel U; Snijders PJ; Meijer CJ; Viscidi R; Muñoz N; Franceschi S;
    J Natl Cancer Inst; 2003 Dec; 95(23):1772-83. PubMed ID: 14652239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis.
    Lang Kuhs KA; Anantharaman D; Waterboer T; Johansson M; Brennan P; Michel A; Willhauck-Fleckenstein M; Purdue MP; Holcátová I; Ahrens W; Lagiou P; Polesel J; Simonato L; Merletti F; Healy CM; Kjaerheim K; Conway DI; Macfarlane TV; Thomson P; Castellsagué X; Znaor A; Black A; Huang WY; Krogh V; Trichopoulou A; Bueno-de-Mesquita HB; Clavel-Chapelon F; Weiderpass E; Ekström J; Riboli E; Tjønneland A; Sánchez MJ; Travis RC; Hildesheim A; Pawlita M; Kreimer AR
    Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):683-9. PubMed ID: 25623733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus (HPV) infection and the risk of esophageal squamous cell carcinoma.
    Qi Z; Jiang Q; Yang J; Chen X; Wu H; Huang L; Hu G; Yuan X
    Dis Esophagus; 2013 Jan; 26(1):61-7. PubMed ID: 22404505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway.
    Bjørge T; Hakulinen T; Engeland A; Jellum E; Koskela P; Lehtinen M; Luostarinen T; Paavonen J; Sapp M; Schiller J; Thoresen S; Wang Z; Youngman L; Dillner J
    Cancer Res; 1997 Sep; 57(18):3989-92. PubMed ID: 9307283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer.
    Applebaum KM; Furniss CS; Zeka A; Posner MR; Smith JF; Bryan J; Eisen EA; Peters ES; McClean MD; Kelsey KT
    J Natl Cancer Inst; 2007 Dec; 99(23):1801-10. PubMed ID: 18042931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals.
    Masini C; Fuchs PG; Gabrielli F; Stark S; Sera F; Ploner M; Melchi CF; Primavera G; Pirchio G; Picconi O; Petasecca P; Cattaruzza MS; Pfister HJ; Abeni D
    Arch Dermatol; 2003 Jul; 139(7):890-4. PubMed ID: 12873884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.
    Viscidi RP; Kotloff KL; Clayman B; Russ K; Shapiro S; Shah KV
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):122-6. PubMed ID: 9067643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.
    Schwartz SM; Daling JR; Doody DR; Wipf GC; Carter JJ; Madeleine MM; Mao EJ; Fitzgibbons ED; Huang S; Beckmann AM; McDougall JK; Galloway DA
    J Natl Cancer Inst; 1998 Nov; 90(21):1626-36. PubMed ID: 9811312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC).
    Yang J; Liu B; Li W; Xiong H; Qiu H; Fu Q; Chen B; Hu G; Yuan X
    Cancer Epidemiol; 2013 Oct; 37(5):629-33. PubMed ID: 23837945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.
    Dillner J; Lehtinen M; Björge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss RE; Hallmans G; Paavonen J; Sapp M; Schiller JT; Hakulinen T; Thoresen S; Hakama M
    J Natl Cancer Inst; 1997 Sep; 89(17):1293-9. PubMed ID: 9293920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization.
    Chang F; Syrjänen S; Shen Q; Cintorino M; Santopietro R; Tosi P; Syrjänen K
    Scand J Gastroenterol; 2000 Feb; 35(2):123-30. PubMed ID: 10720108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma.
    Heino P; Eklund C; Fredriksson-Shanazarian V; Goldman S; Schiller JT; Dillner J
    J Natl Cancer Inst; 1995 Mar; 87(6):437-40. PubMed ID: 7532227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.